Zobrazeno 1 - 10
of 118
pro vyhledávání: '"L De Rycke"'
Autor:
Evelien Bogaerts, L De Rycke, Yves Samoy, Carlien Brondeel, E. Coppieters, B. Van Ryssen, E. de Bakker, Geert Verhoeven
Publikováno v:
VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT
Meniscusletsels bij de hond worden bijna steeds in combinatie met een gescheurde voorste kruisband gezien. Telkens gaat het om de mediale meniscus. Erg manken of een plotse toename van manken kan wijzen op een meniscusletsel bij honden met een kruisb
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jimmy Saunders, L. De Rycke
Publikováno v:
VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT
In dit artikel wordt een overzicht gegeven van aangeboren afwijkingen van de wervels bij honden. Vertebrale anomalieen komen geregeld voor bij deze dieren en kunnen onderverdeeld worden in twee grote groepen, namelijk spinaal dysrafisme zoals spina b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56695a4b647ee0b7c075613031c2ba2d
https://biblio.ugent.be/publication/8528549
https://biblio.ugent.be/publication/8528549
Publikováno v:
Journal of Veterinary Dentistry. 28:172-181
Four domestic pet rabbits with dental pathology were presented at a university clinic. In addition to conducting physical examinations of the rabbits, radiographic and computed tomographic (CT) images of the rabbits' heads were obtained. Three rabbit
Autor:
Timothy B. Niewold, P. P. Tak, Mary K. Crow, Carla A. Wijbrandts, Clio P. Mavragani, Dominique Baeten, T Niers, Bernard Vandooren, Tineke Cantaert, Eric Veys, D Richel, L De Rycke
Publikováno v:
Annals of the rheumatic diseases, 68(6), 1022-1029. BMJ Publishing Group
Annals of the Rheumatic Diseases, 68(6), 1022-1029. BMJ Publishing Group
Annals of the Rheumatic Diseases, 68(6), 1022-1029. BMJ Publishing Group
Objective: Type I interferons and apoptotic particles contribute to antinuclear autoimmunity in experimental models. This study assessed whether similar mechanisms contribute to break peripheral B-cell tolerance in humans by studying the induction of
Publikováno v:
Autoimmunity Reviews. 4:468-474
Anti-citrullinated protein/peptide antibodies (ACPA) are highly specific and sensitive markers for rheumatoid arthritis (RA). For instance, for the anti-CCP2 assay, sensitivities ranging from 55% to 80% and specificities ranging from 90% to 98% have
Publikováno v:
Anatomia, histologia, embryologia. 43(6)
This study was performed to provide a detailed atlas of the normal arterial and venous canine vasculature in the cranial abdomen by dual-phase computed tomographic angiography. Five adult beagles were positioned in dorsal recumbency on a multislice h
Autor:
Annemieke M. H. Boots, Eric Veys, L De Rycke, P. P. Tak, M-J van Lierop, F De Keyser, Peter Verdonk, Dominique Baeten, Frank P. Luyten, E. Bos, Bernard Vandooren, Tineke Cantaert, Barry Bresnihan
Publikováno v:
Annals of the rheumatic diseases, 68(6), 1044-1050. BMJ Publishing Group
Annals of the Rheumatic Diseases, 68(6), 1044-1050. BMJ Publishing Group
Annals of the Rheumatic Diseases, 68(6), 1044-1050. BMJ Publishing Group
Objective: In mice, melanoma inhibitory activity (MIA) is a chondrocyte-specific molecule with similar regulation to collagen type II. As MIA is a small secreted protein, its value as cartilage biomarker in human inflammatory arthritis was assessed.
A few years ago, the immunomodulatory molecule leflunomide was licensed as a new disease modifying anti-rheumatic drug (DMARD) for the treatment of rheumatoid arthritis (RA). Several randomised clinical trials have established its safety and efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1a21c187dc1b4429f7280e97f415b91
https://europepmc.org/articles/PMC1798179/
https://europepmc.org/articles/PMC1798179/
Publikováno v:
Lupus. 14(12)
Since the first proof of efficacy of TNFalpha blockade, both the number of patients treated worldwide and the number of indications for treatment with TNFalpha blockers have grown steadily. Surprisingly, the profound immunomodulation induced by anti-